Global Leukotriene Inhibitors Production, Demand and Key Producers, 2022-2028
Leukotriene inhibitors, also known as antileukotrienes or leukotriene modifiers, is a medication widely used to treat respiratory diseases associated with an allergic response. It works by preventing leukotrienes, inflammatory mediators from binding to their receptors.
This report studies the global Leukotriene Inhibitors production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Leukotriene Inhibitors, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Leukotriene Inhibitors that contribute to its increasing demand across many markets.
The global Leukotriene Inhibitors market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Leukotriene Inhibitors total production and demand, 2017-2028, (K Units)
Global Leukotriene Inhibitors total production value, 2017-2028, (USD Million)
Global Leukotriene Inhibitors production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Leukotriene Inhibitors consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Leukotriene Inhibitors domestic production, consumption, key domestic manufacturers and share
Global Leukotriene Inhibitors production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Leukotriene Inhibitors production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Leukotriene Inhibitors production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Leukotriene Inhibitors market based on the following parameters – headquarters, production locations, products portfolio, Leukotriene Inhibitors revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Leukotriene Inhibitors market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Leukotriene Inhibitors Market, By Region:
1. How big is the global Leukotriene Inhibitors market?
2. What is the demand of the global Leukotriene Inhibitors market?
3. What is the year over year growth of the global Leukotriene Inhibitors market?
4. What is the production and production value of the global Leukotriene Inhibitors market?
5. Who are the key producers in the global Leukotriene Inhibitors market?
6. What are the growth factors driving the market demand?
This report studies the global Leukotriene Inhibitors production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Leukotriene Inhibitors, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Leukotriene Inhibitors that contribute to its increasing demand across many markets.
The global Leukotriene Inhibitors market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Leukotriene Inhibitors total production and demand, 2017-2028, (K Units)
Global Leukotriene Inhibitors total production value, 2017-2028, (USD Million)
Global Leukotriene Inhibitors production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Leukotriene Inhibitors consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Leukotriene Inhibitors domestic production, consumption, key domestic manufacturers and share
Global Leukotriene Inhibitors production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Leukotriene Inhibitors production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Leukotriene Inhibitors production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Leukotriene Inhibitors market based on the following parameters – headquarters, production locations, products portfolio, Leukotriene Inhibitors revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Leukotriene Inhibitors market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Leukotriene Inhibitors Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Montelukast
- Zafirlukast
- Proust
- Other
- Asthma
- COPD
- Allergic Rhinitis
- Other
- Mallinckrodt plc
- Sun Pharmaceutical Industries Ltd
- Novartis AG
- Endo Pharmaceuticals plc
- Zydus Cadila
- Mylan NV
- Mayne Pharma Group Limited
- Teva Pharmaceutical Industries Ltd
- Amneal Pharmaceutical Inc
- Avet Pharmaceuticals Inc
- Aurobindo Pharma
- GSK plc
- Almirall, SA
- Merck & Co., Inc
- Bausch Health
- Sandoz International GmbH
- Pfizer Inc
- AstraZeneca
- Sanofi
- Bayer AG
- McKesson Corporation
1. How big is the global Leukotriene Inhibitors market?
2. What is the demand of the global Leukotriene Inhibitors market?
3. What is the year over year growth of the global Leukotriene Inhibitors market?
4. What is the production and production value of the global Leukotriene Inhibitors market?
5. Who are the key producers in the global Leukotriene Inhibitors market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Leukotriene Inhibitors Introduction
1.2 World Leukotriene Inhibitors Supply & Forecast
1.2.1 World Leukotriene Inhibitors Production Value (2017 & 2021 & 2028)
1.2.2 World Leukotriene Inhibitors Production (2017-2028)
1.2.3 World Leukotriene Inhibitors Pricing Trends (2017-2028)
1.3 World Leukotriene Inhibitors Production by Region
1.3.1 World Leukotriene Inhibitors Production Value by Region (2017-2028)
1.3.2 World Leukotriene Inhibitors Production by Region (2017-2028)
1.3.3 World Leukotriene Inhibitors Average Price by Region (2017-2028)
1.3.4 North America Leukotriene Inhibitors Production (2017-2028)
1.3.5 Europe Leukotriene Inhibitors Production (2017-2028)
1.3.6 China Leukotriene Inhibitors Production (2017-2028)
1.3.7 Japan Leukotriene Inhibitors Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Leukotriene Inhibitors Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Leukotriene Inhibitors Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Leukotriene Inhibitors Demand (2017-2028)
2.2 World Leukotriene Inhibitors Consumption by Region
2.2.1 World Leukotriene Inhibitors Consumption by Region (2017-2022)
2.2.2 World Leukotriene Inhibitors Consumption Forecast by Region (2023-2028)
2.3 United States Leukotriene Inhibitors Consumption (2017-2028)
2.4 China Leukotriene Inhibitors Consumption (2017-2028)
2.5 Europe Leukotriene Inhibitors Consumption (2017-2028)
2.6 Japan Leukotriene Inhibitors Consumption (2017-2028)
2.7 South Korea Leukotriene Inhibitors Consumption (2017-2028)
2.8 ASEAN Leukotriene Inhibitors Consumption (2017-2028)
2.9 India Leukotriene Inhibitors Consumption (2017-2028)
3 WORLD LEUKOTRIENE INHIBITORS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Leukotriene Inhibitors Production Value by Manufacturer (2017-2022)
3.2 World Leukotriene Inhibitors Production by Manufacturer (2017-2022)
3.3 World Leukotriene Inhibitors Average Price by Manufacturer (2017-2022)
3.4 Leukotriene Inhibitors Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Leukotriene Inhibitors Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Leukotriene Inhibitors in 2021
3.5.3 Global Concentration Ratios (CR8) for Leukotriene Inhibitors in 2021
3.6 Leukotriene Inhibitors Market: Overall Company Footprint Analysis
3.6.1 Leukotriene Inhibitors Market: Region Footprint
3.6.2 Leukotriene Inhibitors Market: Company Product Type Footprint
3.6.3 Leukotriene Inhibitors Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Leukotriene Inhibitors Production Value Comparison
4.1.1 United States VS China: Leukotriene Inhibitors Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Leukotriene Inhibitors Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Leukotriene Inhibitors Production Comparison
4.2.1 United States VS China: Leukotriene Inhibitors Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Leukotriene Inhibitors Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Leukotriene Inhibitors Consumption Comparison
4.3.1 United States VS China: Leukotriene Inhibitors Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Leukotriene Inhibitors Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Leukotriene Inhibitors Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Leukotriene Inhibitors in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Leukotriene Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Leukotriene Inhibitors Production by Domestic Manufacturer, (2017-2022)
4.5 China Leukotriene Inhibitors Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Leukotriene Inhibitors in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Leukotriene Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Leukotriene Inhibitors Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Leukotriene Inhibitors Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Leukotriene Inhibitors in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Leukotriene Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Leukotriene Inhibitors Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Leukotriene Inhibitors Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Montelukast
5.2.2 Zafirlukast
5.2.3 Proust
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Leukotriene Inhibitors Production by Type (2017-2028)
5.3.2 World Leukotriene Inhibitors Production Value by Type (2017-2028)
5.3.3 World Leukotriene Inhibitors Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Leukotriene Inhibitors Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Asthma
6.2.2 COPD
6.2.3 Allergic Rhinitis
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Leukotriene Inhibitors Production by Application (2017-2028)
6.3.2 World Leukotriene Inhibitors Production Value by Application (2017-2028)
6.3.3 World Leukotriene Inhibitors Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Mallinckrodt plc
7.1.1 Mallinckrodt plc Details
7.1.2 Mallinckrodt plc Major Business
7.1.3 Mallinckrodt plc Leukotriene Inhibitors Product and Services
7.1.4 Mallinckrodt plc Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Mallinckrodt plc Recent Developments/Updates
7.1.6 Mallinckrodt plc Competitive Strengths & Weaknesses
7.2 Sun Pharmaceutical Industries Ltd
7.2.1 Sun Pharmaceutical Industries Ltd Details
7.2.2 Sun Pharmaceutical Industries Ltd Major Business
7.2.3 Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Product and Services
7.2.4 Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
7.2.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.3 Novartis AG
7.3.1 Novartis AG Details
7.3.2 Novartis AG Major Business
7.3.3 Novartis AG Leukotriene Inhibitors Product and Services
7.3.4 Novartis AG Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Novartis AG Recent Developments/Updates
7.3.6 Novartis AG Competitive Strengths & Weaknesses
7.4 Endo Pharmaceuticals plc
7.4.1 Endo Pharmaceuticals plc Details
7.4.2 Endo Pharmaceuticals plc Major Business
7.4.3 Endo Pharmaceuticals plc Leukotriene Inhibitors Product and Services
7.4.4 Endo Pharmaceuticals plc Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Endo Pharmaceuticals plc Recent Developments/Updates
7.4.6 Endo Pharmaceuticals plc Competitive Strengths & Weaknesses
7.5 Zydus Cadila
7.5.1 Zydus Cadila Details
7.5.2 Zydus Cadila Major Business
7.5.3 Zydus Cadila Leukotriene Inhibitors Product and Services
7.5.4 Zydus Cadila Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Zydus Cadila Recent Developments/Updates
7.5.6 Zydus Cadila Competitive Strengths & Weaknesses
7.6 Mylan NV
7.6.1 Mylan NV Details
7.6.2 Mylan NV Major Business
7.6.3 Mylan NV Leukotriene Inhibitors Product and Services
7.6.4 Mylan NV Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Mylan NV Recent Developments/Updates
7.6.6 Mylan NV Competitive Strengths & Weaknesses
7.7 Mayne Pharma Group Limited
7.7.1 Mayne Pharma Group Limited Details
7.7.2 Mayne Pharma Group Limited Major Business
7.7.3 Mayne Pharma Group Limited Leukotriene Inhibitors Product and Services
7.7.4 Mayne Pharma Group Limited Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Mayne Pharma Group Limited Recent Developments/Updates
7.7.6 Mayne Pharma Group Limited Competitive Strengths & Weaknesses
7.8 Teva Pharmaceutical Industries Ltd
7.8.1 Teva Pharmaceutical Industries Ltd Details
7.8.2 Teva Pharmaceutical Industries Ltd Major Business
7.8.3 Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Product and Services
7.8.4 Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.8.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.9 Amneal Pharmaceutical Inc
7.9.1 Amneal Pharmaceutical Inc Details
7.9.2 Amneal Pharmaceutical Inc Major Business
7.9.3 Amneal Pharmaceutical Inc Leukotriene Inhibitors Product and Services
7.9.4 Amneal Pharmaceutical Inc Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Amneal Pharmaceutical Inc Recent Developments/Updates
7.9.6 Amneal Pharmaceutical Inc Competitive Strengths & Weaknesses
7.10 Avet Pharmaceuticals Inc
7.10.1 Avet Pharmaceuticals Inc Details
7.10.2 Avet Pharmaceuticals Inc Major Business
7.10.3 Avet Pharmaceuticals Inc Leukotriene Inhibitors Product and Services
7.10.4 Avet Pharmaceuticals Inc Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Avet Pharmaceuticals Inc Recent Developments/Updates
7.10.6 Avet Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.11 Aurobindo Pharma
7.11.1 Aurobindo Pharma Details
7.11.2 Aurobindo Pharma Major Business
7.11.3 Aurobindo Pharma Leukotriene Inhibitors Product and Services
7.11.4 Aurobindo Pharma Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Aurobindo Pharma Recent Developments/Updates
7.11.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.12 GSK plc
7.12.1 GSK plc Details
7.12.2 GSK plc Major Business
7.12.3 GSK plc Leukotriene Inhibitors Product and Services
7.12.4 GSK plc Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 GSK plc Recent Developments/Updates
7.12.6 GSK plc Competitive Strengths & Weaknesses
7.13 Almirall, SA
7.13.1 Almirall, SA Details
7.13.2 Almirall, SA Major Business
7.13.3 Almirall, SA Leukotriene Inhibitors Product and Services
7.13.4 Almirall, SA Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Almirall, SA Recent Developments/Updates
7.13.6 Almirall, SA Competitive Strengths & Weaknesses
7.14 Merck & Co., Inc
7.14.1 Merck & Co., Inc Details
7.14.2 Merck & Co., Inc Major Business
7.14.3 Merck & Co., Inc Leukotriene Inhibitors Product and Services
7.14.4 Merck & Co., Inc Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Merck & Co., Inc Recent Developments/Updates
7.14.6 Merck & Co., Inc Competitive Strengths & Weaknesses
7.15 Bausch Health
7.15.1 Bausch Health Details
7.15.2 Bausch Health Major Business
7.15.3 Bausch Health Leukotriene Inhibitors Product and Services
7.15.4 Bausch Health Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Bausch Health Recent Developments/Updates
7.15.6 Bausch Health Competitive Strengths & Weaknesses
7.16 Sandoz International GmbH
7.16.1 Sandoz International GmbH Details
7.16.2 Sandoz International GmbH Major Business
7.16.3 Sandoz International GmbH Leukotriene Inhibitors Product and Services
7.16.4 Sandoz International GmbH Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Sandoz International GmbH Recent Developments/Updates
7.16.6 Sandoz International GmbH Competitive Strengths & Weaknesses
7.17 Pfizer Inc
7.17.1 Pfizer Inc Details
7.17.2 Pfizer Inc Major Business
7.17.3 Pfizer Inc Leukotriene Inhibitors Product and Services
7.17.4 Pfizer Inc Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Pfizer Inc Recent Developments/Updates
7.17.6 Pfizer Inc Competitive Strengths & Weaknesses
7.18 AstraZeneca
7.18.1 AstraZeneca Details
7.18.2 AstraZeneca Major Business
7.18.3 AstraZeneca Leukotriene Inhibitors Product and Services
7.18.4 AstraZeneca Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 AstraZeneca Recent Developments/Updates
7.18.6 AstraZeneca Competitive Strengths & Weaknesses
7.19 Sanofi
7.19.1 Sanofi Details
7.19.2 Sanofi Major Business
7.19.3 Sanofi Leukotriene Inhibitors Product and Services
7.19.4 Sanofi Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 Sanofi Recent Developments/Updates
7.19.6 Sanofi Competitive Strengths & Weaknesses
7.20 Bayer AG
7.20.1 Bayer AG Details
7.20.2 Bayer AG Major Business
7.20.3 Bayer AG Leukotriene Inhibitors Product and Services
7.20.4 Bayer AG Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.20.5 Bayer AG Recent Developments/Updates
7.20.6 Bayer AG Competitive Strengths & Weaknesses
7.21 McKesson Corporation
7.21.1 McKesson Corporation Details
7.21.2 McKesson Corporation Major Business
7.21.3 McKesson Corporation Leukotriene Inhibitors Product and Services
7.21.4 McKesson Corporation Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.21.5 McKesson Corporation Recent Developments/Updates
7.21.6 McKesson Corporation Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Leukotriene Inhibitors and Key Manufacturers
8.2 Leukotriene Inhibitors Manufacturing Costs
8.3 Leukotriene Inhibitors Production Process
8.4 Leukotriene Inhibitors Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Leukotriene Inhibitors Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Leukotriene Inhibitors Typical Distributors
9.3 Leukotriene Inhibitors Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Leukotriene Inhibitors Introduction
1.2 World Leukotriene Inhibitors Supply & Forecast
1.2.1 World Leukotriene Inhibitors Production Value (2017 & 2021 & 2028)
1.2.2 World Leukotriene Inhibitors Production (2017-2028)
1.2.3 World Leukotriene Inhibitors Pricing Trends (2017-2028)
1.3 World Leukotriene Inhibitors Production by Region
1.3.1 World Leukotriene Inhibitors Production Value by Region (2017-2028)
1.3.2 World Leukotriene Inhibitors Production by Region (2017-2028)
1.3.3 World Leukotriene Inhibitors Average Price by Region (2017-2028)
1.3.4 North America Leukotriene Inhibitors Production (2017-2028)
1.3.5 Europe Leukotriene Inhibitors Production (2017-2028)
1.3.6 China Leukotriene Inhibitors Production (2017-2028)
1.3.7 Japan Leukotriene Inhibitors Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Leukotriene Inhibitors Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Leukotriene Inhibitors Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Leukotriene Inhibitors Demand (2017-2028)
2.2 World Leukotriene Inhibitors Consumption by Region
2.2.1 World Leukotriene Inhibitors Consumption by Region (2017-2022)
2.2.2 World Leukotriene Inhibitors Consumption Forecast by Region (2023-2028)
2.3 United States Leukotriene Inhibitors Consumption (2017-2028)
2.4 China Leukotriene Inhibitors Consumption (2017-2028)
2.5 Europe Leukotriene Inhibitors Consumption (2017-2028)
2.6 Japan Leukotriene Inhibitors Consumption (2017-2028)
2.7 South Korea Leukotriene Inhibitors Consumption (2017-2028)
2.8 ASEAN Leukotriene Inhibitors Consumption (2017-2028)
2.9 India Leukotriene Inhibitors Consumption (2017-2028)
3 WORLD LEUKOTRIENE INHIBITORS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Leukotriene Inhibitors Production Value by Manufacturer (2017-2022)
3.2 World Leukotriene Inhibitors Production by Manufacturer (2017-2022)
3.3 World Leukotriene Inhibitors Average Price by Manufacturer (2017-2022)
3.4 Leukotriene Inhibitors Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Leukotriene Inhibitors Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Leukotriene Inhibitors in 2021
3.5.3 Global Concentration Ratios (CR8) for Leukotriene Inhibitors in 2021
3.6 Leukotriene Inhibitors Market: Overall Company Footprint Analysis
3.6.1 Leukotriene Inhibitors Market: Region Footprint
3.6.2 Leukotriene Inhibitors Market: Company Product Type Footprint
3.6.3 Leukotriene Inhibitors Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Leukotriene Inhibitors Production Value Comparison
4.1.1 United States VS China: Leukotriene Inhibitors Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Leukotriene Inhibitors Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Leukotriene Inhibitors Production Comparison
4.2.1 United States VS China: Leukotriene Inhibitors Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Leukotriene Inhibitors Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Leukotriene Inhibitors Consumption Comparison
4.3.1 United States VS China: Leukotriene Inhibitors Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Leukotriene Inhibitors Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Leukotriene Inhibitors Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Leukotriene Inhibitors in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Leukotriene Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Leukotriene Inhibitors Production by Domestic Manufacturer, (2017-2022)
4.5 China Leukotriene Inhibitors Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Leukotriene Inhibitors in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Leukotriene Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Leukotriene Inhibitors Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Leukotriene Inhibitors Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Leukotriene Inhibitors in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Leukotriene Inhibitors Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Leukotriene Inhibitors Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Leukotriene Inhibitors Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Montelukast
5.2.2 Zafirlukast
5.2.3 Proust
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Leukotriene Inhibitors Production by Type (2017-2028)
5.3.2 World Leukotriene Inhibitors Production Value by Type (2017-2028)
5.3.3 World Leukotriene Inhibitors Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Leukotriene Inhibitors Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Asthma
6.2.2 COPD
6.2.3 Allergic Rhinitis
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Leukotriene Inhibitors Production by Application (2017-2028)
6.3.2 World Leukotriene Inhibitors Production Value by Application (2017-2028)
6.3.3 World Leukotriene Inhibitors Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Mallinckrodt plc
7.1.1 Mallinckrodt plc Details
7.1.2 Mallinckrodt plc Major Business
7.1.3 Mallinckrodt plc Leukotriene Inhibitors Product and Services
7.1.4 Mallinckrodt plc Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Mallinckrodt plc Recent Developments/Updates
7.1.6 Mallinckrodt plc Competitive Strengths & Weaknesses
7.2 Sun Pharmaceutical Industries Ltd
7.2.1 Sun Pharmaceutical Industries Ltd Details
7.2.2 Sun Pharmaceutical Industries Ltd Major Business
7.2.3 Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Product and Services
7.2.4 Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
7.2.6 Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.3 Novartis AG
7.3.1 Novartis AG Details
7.3.2 Novartis AG Major Business
7.3.3 Novartis AG Leukotriene Inhibitors Product and Services
7.3.4 Novartis AG Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Novartis AG Recent Developments/Updates
7.3.6 Novartis AG Competitive Strengths & Weaknesses
7.4 Endo Pharmaceuticals plc
7.4.1 Endo Pharmaceuticals plc Details
7.4.2 Endo Pharmaceuticals plc Major Business
7.4.3 Endo Pharmaceuticals plc Leukotriene Inhibitors Product and Services
7.4.4 Endo Pharmaceuticals plc Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Endo Pharmaceuticals plc Recent Developments/Updates
7.4.6 Endo Pharmaceuticals plc Competitive Strengths & Weaknesses
7.5 Zydus Cadila
7.5.1 Zydus Cadila Details
7.5.2 Zydus Cadila Major Business
7.5.3 Zydus Cadila Leukotriene Inhibitors Product and Services
7.5.4 Zydus Cadila Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Zydus Cadila Recent Developments/Updates
7.5.6 Zydus Cadila Competitive Strengths & Weaknesses
7.6 Mylan NV
7.6.1 Mylan NV Details
7.6.2 Mylan NV Major Business
7.6.3 Mylan NV Leukotriene Inhibitors Product and Services
7.6.4 Mylan NV Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Mylan NV Recent Developments/Updates
7.6.6 Mylan NV Competitive Strengths & Weaknesses
7.7 Mayne Pharma Group Limited
7.7.1 Mayne Pharma Group Limited Details
7.7.2 Mayne Pharma Group Limited Major Business
7.7.3 Mayne Pharma Group Limited Leukotriene Inhibitors Product and Services
7.7.4 Mayne Pharma Group Limited Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 Mayne Pharma Group Limited Recent Developments/Updates
7.7.6 Mayne Pharma Group Limited Competitive Strengths & Weaknesses
7.8 Teva Pharmaceutical Industries Ltd
7.8.1 Teva Pharmaceutical Industries Ltd Details
7.8.2 Teva Pharmaceutical Industries Ltd Major Business
7.8.3 Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Product and Services
7.8.4 Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.8.6 Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
7.9 Amneal Pharmaceutical Inc
7.9.1 Amneal Pharmaceutical Inc Details
7.9.2 Amneal Pharmaceutical Inc Major Business
7.9.3 Amneal Pharmaceutical Inc Leukotriene Inhibitors Product and Services
7.9.4 Amneal Pharmaceutical Inc Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Amneal Pharmaceutical Inc Recent Developments/Updates
7.9.6 Amneal Pharmaceutical Inc Competitive Strengths & Weaknesses
7.10 Avet Pharmaceuticals Inc
7.10.1 Avet Pharmaceuticals Inc Details
7.10.2 Avet Pharmaceuticals Inc Major Business
7.10.3 Avet Pharmaceuticals Inc Leukotriene Inhibitors Product and Services
7.10.4 Avet Pharmaceuticals Inc Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Avet Pharmaceuticals Inc Recent Developments/Updates
7.10.6 Avet Pharmaceuticals Inc Competitive Strengths & Weaknesses
7.11 Aurobindo Pharma
7.11.1 Aurobindo Pharma Details
7.11.2 Aurobindo Pharma Major Business
7.11.3 Aurobindo Pharma Leukotriene Inhibitors Product and Services
7.11.4 Aurobindo Pharma Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Aurobindo Pharma Recent Developments/Updates
7.11.6 Aurobindo Pharma Competitive Strengths & Weaknesses
7.12 GSK plc
7.12.1 GSK plc Details
7.12.2 GSK plc Major Business
7.12.3 GSK plc Leukotriene Inhibitors Product and Services
7.12.4 GSK plc Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 GSK plc Recent Developments/Updates
7.12.6 GSK plc Competitive Strengths & Weaknesses
7.13 Almirall, SA
7.13.1 Almirall, SA Details
7.13.2 Almirall, SA Major Business
7.13.3 Almirall, SA Leukotriene Inhibitors Product and Services
7.13.4 Almirall, SA Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Almirall, SA Recent Developments/Updates
7.13.6 Almirall, SA Competitive Strengths & Weaknesses
7.14 Merck & Co., Inc
7.14.1 Merck & Co., Inc Details
7.14.2 Merck & Co., Inc Major Business
7.14.3 Merck & Co., Inc Leukotriene Inhibitors Product and Services
7.14.4 Merck & Co., Inc Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Merck & Co., Inc Recent Developments/Updates
7.14.6 Merck & Co., Inc Competitive Strengths & Weaknesses
7.15 Bausch Health
7.15.1 Bausch Health Details
7.15.2 Bausch Health Major Business
7.15.3 Bausch Health Leukotriene Inhibitors Product and Services
7.15.4 Bausch Health Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Bausch Health Recent Developments/Updates
7.15.6 Bausch Health Competitive Strengths & Weaknesses
7.16 Sandoz International GmbH
7.16.1 Sandoz International GmbH Details
7.16.2 Sandoz International GmbH Major Business
7.16.3 Sandoz International GmbH Leukotriene Inhibitors Product and Services
7.16.4 Sandoz International GmbH Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Sandoz International GmbH Recent Developments/Updates
7.16.6 Sandoz International GmbH Competitive Strengths & Weaknesses
7.17 Pfizer Inc
7.17.1 Pfizer Inc Details
7.17.2 Pfizer Inc Major Business
7.17.3 Pfizer Inc Leukotriene Inhibitors Product and Services
7.17.4 Pfizer Inc Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Pfizer Inc Recent Developments/Updates
7.17.6 Pfizer Inc Competitive Strengths & Weaknesses
7.18 AstraZeneca
7.18.1 AstraZeneca Details
7.18.2 AstraZeneca Major Business
7.18.3 AstraZeneca Leukotriene Inhibitors Product and Services
7.18.4 AstraZeneca Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 AstraZeneca Recent Developments/Updates
7.18.6 AstraZeneca Competitive Strengths & Weaknesses
7.19 Sanofi
7.19.1 Sanofi Details
7.19.2 Sanofi Major Business
7.19.3 Sanofi Leukotriene Inhibitors Product and Services
7.19.4 Sanofi Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 Sanofi Recent Developments/Updates
7.19.6 Sanofi Competitive Strengths & Weaknesses
7.20 Bayer AG
7.20.1 Bayer AG Details
7.20.2 Bayer AG Major Business
7.20.3 Bayer AG Leukotriene Inhibitors Product and Services
7.20.4 Bayer AG Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.20.5 Bayer AG Recent Developments/Updates
7.20.6 Bayer AG Competitive Strengths & Weaknesses
7.21 McKesson Corporation
7.21.1 McKesson Corporation Details
7.21.2 McKesson Corporation Major Business
7.21.3 McKesson Corporation Leukotriene Inhibitors Product and Services
7.21.4 McKesson Corporation Leukotriene Inhibitors Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.21.5 McKesson Corporation Recent Developments/Updates
7.21.6 McKesson Corporation Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Leukotriene Inhibitors and Key Manufacturers
8.2 Leukotriene Inhibitors Manufacturing Costs
8.3 Leukotriene Inhibitors Production Process
8.4 Leukotriene Inhibitors Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Leukotriene Inhibitors Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Leukotriene Inhibitors Typical Distributors
9.3 Leukotriene Inhibitors Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Leukotriene Inhibitors Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Leukotriene Inhibitors Production Value by Region (2017-2022) & (USD Million)
Table 3. World Leukotriene Inhibitors Production Value by Region (2023-2028) & (USD Million)
Table 4. World Leukotriene Inhibitors Production Value Market Share by Region (2017-2022)
Table 5. World Leukotriene Inhibitors Production Value Market Share by Region (2023-2028)
Table 6. World Leukotriene Inhibitors Production by Region (2017-2022) & (K Units)
Table 7. World Leukotriene Inhibitors Production by Region (2023-2028) & (K Units)
Table 8. World Leukotriene Inhibitors Production Market Share by Region (2017-2022)
Table 9. World Leukotriene Inhibitors Production Market Share by Region (2023-2028)
Table 10. World Leukotriene Inhibitors Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Leukotriene Inhibitors Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Leukotriene Inhibitors Major Market Trends
Table 13. World Leukotriene Inhibitors Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Leukotriene Inhibitors Consumption by Region (2017-2022) & (K Units)
Table 15. World Leukotriene Inhibitors Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Leukotriene Inhibitors Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Leukotriene Inhibitors Producers in 2021
Table 18. World Leukotriene Inhibitors Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Leukotriene Inhibitors Producers in 2021
Table 20. World Leukotriene Inhibitors Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Leukotriene Inhibitors Company Evaluation Quadrant
Table 22. World Leukotriene Inhibitors Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Leukotriene Inhibitors Production Site of Key Manufacturer
Table 24. Leukotriene Inhibitors Market: Company Product Type Footprint
Table 25. Leukotriene Inhibitors Market: Company Product Application Footprint
Table 26. Leukotriene Inhibitors Competitive Factors
Table 27. Leukotriene Inhibitors New Entrant and Capacity Expansion Plans
Table 28. Leukotriene Inhibitors Mergers & Acquisitions Activity
Table 29. United States VS China Leukotriene Inhibitors Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Leukotriene Inhibitors Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Leukotriene Inhibitors Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Leukotriene Inhibitors in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Leukotriene Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Leukotriene Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Leukotriene Inhibitors Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Leukotriene Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Leukotriene Inhibitors in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Leukotriene Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Leukotriene Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Leukotriene Inhibitors Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Leukotriene Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Leukotriene Inhibitors in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Leukotriene Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Leukotriene Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Leukotriene Inhibitors Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Leukotriene Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Leukotriene Inhibitors Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Leukotriene Inhibitors Production by Type (2017-2022) & (K Units)
Table 49. World Leukotriene Inhibitors Production by Type (2023-2028) & (K Units)
Table 50. World Leukotriene Inhibitors Production Value by Type (2017-2022) & (USD Million)
Table 51. World Leukotriene Inhibitors Production Value by Type (2023-2028) & (USD Million)
Table 52. World Leukotriene Inhibitors Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Leukotriene Inhibitors Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Leukotriene Inhibitors Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Leukotriene Inhibitors Production by Application (2017-2022) & (K Units)
Table 56. World Leukotriene Inhibitors Production by Application (2023-2028) & (K Units)
Table 57. World Leukotriene Inhibitors Production Value by Application (2017-2022) & (USD Million)
Table 58. World Leukotriene Inhibitors Production Value by Application (2023-2028) & (USD Million)
Table 59. World Leukotriene Inhibitors Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Leukotriene Inhibitors Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Mallinckrodt plc Basic Information, Manufacturing Base and Competitors
Table 62. Mallinckrodt plc Major Business
Table 63. Mallinckrodt plc Leukotriene Inhibitors Product and Services
Table 64. Mallinckrodt plc Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Mallinckrodt plc Recent Developments/Updates
Table 66. Mallinckrodt plc Competitive Strengths & Weaknesses
Table 67. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 68. Sun Pharmaceutical Industries Ltd Major Business
Table 69. Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Product and Services
Table 70. Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 72. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 73. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 74. Novartis AG Major Business
Table 75. Novartis AG Leukotriene Inhibitors Product and Services
Table 76. Novartis AG Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Novartis AG Recent Developments/Updates
Table 78. Novartis AG Competitive Strengths & Weaknesses
Table 79. Endo Pharmaceuticals plc Basic Information, Manufacturing Base and Competitors
Table 80. Endo Pharmaceuticals plc Major Business
Table 81. Endo Pharmaceuticals plc Leukotriene Inhibitors Product and Services
Table 82. Endo Pharmaceuticals plc Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Endo Pharmaceuticals plc Recent Developments/Updates
Table 84. Endo Pharmaceuticals plc Competitive Strengths & Weaknesses
Table 85. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 86. Zydus Cadila Major Business
Table 87. Zydus Cadila Leukotriene Inhibitors Product and Services
Table 88. Zydus Cadila Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Zydus Cadila Recent Developments/Updates
Table 90. Zydus Cadila Competitive Strengths & Weaknesses
Table 91. Mylan NV Basic Information, Manufacturing Base and Competitors
Table 92. Mylan NV Major Business
Table 93. Mylan NV Leukotriene Inhibitors Product and Services
Table 94. Mylan NV Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Mylan NV Recent Developments/Updates
Table 96. Mylan NV Competitive Strengths & Weaknesses
Table 97. Mayne Pharma Group Limited Basic Information, Manufacturing Base and Competitors
Table 98. Mayne Pharma Group Limited Major Business
Table 99. Mayne Pharma Group Limited Leukotriene Inhibitors Product and Services
Table 100. Mayne Pharma Group Limited Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Mayne Pharma Group Limited Recent Developments/Updates
Table 102. Mayne Pharma Group Limited Competitive Strengths & Weaknesses
Table 103. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Teva Pharmaceutical Industries Ltd Major Business
Table 105. Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Product and Services
Table 106. Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 108. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 109. Amneal Pharmaceutical Inc Basic Information, Manufacturing Base and Competitors
Table 110. Amneal Pharmaceutical Inc Major Business
Table 111. Amneal Pharmaceutical Inc Leukotriene Inhibitors Product and Services
Table 112. Amneal Pharmaceutical Inc Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Amneal Pharmaceutical Inc Recent Developments/Updates
Table 114. Amneal Pharmaceutical Inc Competitive Strengths & Weaknesses
Table 115. Avet Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 116. Avet Pharmaceuticals Inc Major Business
Table 117. Avet Pharmaceuticals Inc Leukotriene Inhibitors Product and Services
Table 118. Avet Pharmaceuticals Inc Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Avet Pharmaceuticals Inc Recent Developments/Updates
Table 120. Avet Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 121. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 122. Aurobindo Pharma Major Business
Table 123. Aurobindo Pharma Leukotriene Inhibitors Product and Services
Table 124. Aurobindo Pharma Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Aurobindo Pharma Recent Developments/Updates
Table 126. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 127. GSK plc Basic Information, Manufacturing Base and Competitors
Table 128. GSK plc Major Business
Table 129. GSK plc Leukotriene Inhibitors Product and Services
Table 130. GSK plc Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. GSK plc Recent Developments/Updates
Table 132. GSK plc Competitive Strengths & Weaknesses
Table 133. Almirall, SA Basic Information, Manufacturing Base and Competitors
Table 134. Almirall, SA Major Business
Table 135. Almirall, SA Leukotriene Inhibitors Product and Services
Table 136. Almirall, SA Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Almirall, SA Recent Developments/Updates
Table 138. Almirall, SA Competitive Strengths & Weaknesses
Table 139. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 140. Merck & Co., Inc Major Business
Table 141. Merck & Co., Inc Leukotriene Inhibitors Product and Services
Table 142. Merck & Co., Inc Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Merck & Co., Inc Recent Developments/Updates
Table 144. Merck & Co., Inc Competitive Strengths & Weaknesses
Table 145. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 146. Bausch Health Major Business
Table 147. Bausch Health Leukotriene Inhibitors Product and Services
Table 148. Bausch Health Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Bausch Health Recent Developments/Updates
Table 150. Bausch Health Competitive Strengths & Weaknesses
Table 151. Sandoz International GmbH Basic Information, Manufacturing Base and Competitors
Table 152. Sandoz International GmbH Major Business
Table 153. Sandoz International GmbH Leukotriene Inhibitors Product and Services
Table 154. Sandoz International GmbH Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Sandoz International GmbH Recent Developments/Updates
Table 156. Sandoz International GmbH Competitive Strengths & Weaknesses
Table 157. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 158. Pfizer Inc Major Business
Table 159. Pfizer Inc Leukotriene Inhibitors Product and Services
Table 160. Pfizer Inc Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. Pfizer Inc Recent Developments/Updates
Table 162. Pfizer Inc Competitive Strengths & Weaknesses
Table 163. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 164. AstraZeneca Major Business
Table 165. AstraZeneca Leukotriene Inhibitors Product and Services
Table 166. AstraZeneca Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. AstraZeneca Recent Developments/Updates
Table 168. AstraZeneca Competitive Strengths & Weaknesses
Table 169. Sanofi Basic Information, Manufacturing Base and Competitors
Table 170. Sanofi Major Business
Table 171. Sanofi Leukotriene Inhibitors Product and Services
Table 172. Sanofi Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 173. Sanofi Recent Developments/Updates
Table 174. Sanofi Competitive Strengths & Weaknesses
Table 175. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 176. Bayer AG Major Business
Table 177. Bayer AG Leukotriene Inhibitors Product and Services
Table 178. Bayer AG Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 179. Bayer AG Recent Developments/Updates
Table 180. McKesson Corporation Basic Information, Manufacturing Base and Competitors
Table 181. McKesson Corporation Major Business
Table 182. McKesson Corporation Leukotriene Inhibitors Product and Services
Table 183. McKesson Corporation Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 184. Leukotriene Inhibitors Raw Material
Table 185. Key Manufacturers of Leukotriene Inhibitors Raw Materials
Table 186. Leukotriene Inhibitors Typical Distributors
Table 187. Leukotriene Inhibitors Typical Customers
Table 1. World Leukotriene Inhibitors Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Leukotriene Inhibitors Production Value by Region (2017-2022) & (USD Million)
Table 3. World Leukotriene Inhibitors Production Value by Region (2023-2028) & (USD Million)
Table 4. World Leukotriene Inhibitors Production Value Market Share by Region (2017-2022)
Table 5. World Leukotriene Inhibitors Production Value Market Share by Region (2023-2028)
Table 6. World Leukotriene Inhibitors Production by Region (2017-2022) & (K Units)
Table 7. World Leukotriene Inhibitors Production by Region (2023-2028) & (K Units)
Table 8. World Leukotriene Inhibitors Production Market Share by Region (2017-2022)
Table 9. World Leukotriene Inhibitors Production Market Share by Region (2023-2028)
Table 10. World Leukotriene Inhibitors Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Leukotriene Inhibitors Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Leukotriene Inhibitors Major Market Trends
Table 13. World Leukotriene Inhibitors Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Leukotriene Inhibitors Consumption by Region (2017-2022) & (K Units)
Table 15. World Leukotriene Inhibitors Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Leukotriene Inhibitors Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Leukotriene Inhibitors Producers in 2021
Table 18. World Leukotriene Inhibitors Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Leukotriene Inhibitors Producers in 2021
Table 20. World Leukotriene Inhibitors Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Leukotriene Inhibitors Company Evaluation Quadrant
Table 22. World Leukotriene Inhibitors Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Leukotriene Inhibitors Production Site of Key Manufacturer
Table 24. Leukotriene Inhibitors Market: Company Product Type Footprint
Table 25. Leukotriene Inhibitors Market: Company Product Application Footprint
Table 26. Leukotriene Inhibitors Competitive Factors
Table 27. Leukotriene Inhibitors New Entrant and Capacity Expansion Plans
Table 28. Leukotriene Inhibitors Mergers & Acquisitions Activity
Table 29. United States VS China Leukotriene Inhibitors Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Leukotriene Inhibitors Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Leukotriene Inhibitors Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Leukotriene Inhibitors in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Leukotriene Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Leukotriene Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Leukotriene Inhibitors Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Leukotriene Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Leukotriene Inhibitors in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Leukotriene Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Leukotriene Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Leukotriene Inhibitors Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Leukotriene Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Leukotriene Inhibitors in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Leukotriene Inhibitors Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Leukotriene Inhibitors Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Leukotriene Inhibitors Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Leukotriene Inhibitors Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Leukotriene Inhibitors Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Leukotriene Inhibitors Production by Type (2017-2022) & (K Units)
Table 49. World Leukotriene Inhibitors Production by Type (2023-2028) & (K Units)
Table 50. World Leukotriene Inhibitors Production Value by Type (2017-2022) & (USD Million)
Table 51. World Leukotriene Inhibitors Production Value by Type (2023-2028) & (USD Million)
Table 52. World Leukotriene Inhibitors Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Leukotriene Inhibitors Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Leukotriene Inhibitors Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Leukotriene Inhibitors Production by Application (2017-2022) & (K Units)
Table 56. World Leukotriene Inhibitors Production by Application (2023-2028) & (K Units)
Table 57. World Leukotriene Inhibitors Production Value by Application (2017-2022) & (USD Million)
Table 58. World Leukotriene Inhibitors Production Value by Application (2023-2028) & (USD Million)
Table 59. World Leukotriene Inhibitors Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Leukotriene Inhibitors Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Mallinckrodt plc Basic Information, Manufacturing Base and Competitors
Table 62. Mallinckrodt plc Major Business
Table 63. Mallinckrodt plc Leukotriene Inhibitors Product and Services
Table 64. Mallinckrodt plc Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Mallinckrodt plc Recent Developments/Updates
Table 66. Mallinckrodt plc Competitive Strengths & Weaknesses
Table 67. Sun Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 68. Sun Pharmaceutical Industries Ltd Major Business
Table 69. Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Product and Services
Table 70. Sun Pharmaceutical Industries Ltd Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 72. Sun Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 73. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 74. Novartis AG Major Business
Table 75. Novartis AG Leukotriene Inhibitors Product and Services
Table 76. Novartis AG Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Novartis AG Recent Developments/Updates
Table 78. Novartis AG Competitive Strengths & Weaknesses
Table 79. Endo Pharmaceuticals plc Basic Information, Manufacturing Base and Competitors
Table 80. Endo Pharmaceuticals plc Major Business
Table 81. Endo Pharmaceuticals plc Leukotriene Inhibitors Product and Services
Table 82. Endo Pharmaceuticals plc Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Endo Pharmaceuticals plc Recent Developments/Updates
Table 84. Endo Pharmaceuticals plc Competitive Strengths & Weaknesses
Table 85. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 86. Zydus Cadila Major Business
Table 87. Zydus Cadila Leukotriene Inhibitors Product and Services
Table 88. Zydus Cadila Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Zydus Cadila Recent Developments/Updates
Table 90. Zydus Cadila Competitive Strengths & Weaknesses
Table 91. Mylan NV Basic Information, Manufacturing Base and Competitors
Table 92. Mylan NV Major Business
Table 93. Mylan NV Leukotriene Inhibitors Product and Services
Table 94. Mylan NV Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Mylan NV Recent Developments/Updates
Table 96. Mylan NV Competitive Strengths & Weaknesses
Table 97. Mayne Pharma Group Limited Basic Information, Manufacturing Base and Competitors
Table 98. Mayne Pharma Group Limited Major Business
Table 99. Mayne Pharma Group Limited Leukotriene Inhibitors Product and Services
Table 100. Mayne Pharma Group Limited Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Mayne Pharma Group Limited Recent Developments/Updates
Table 102. Mayne Pharma Group Limited Competitive Strengths & Weaknesses
Table 103. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Teva Pharmaceutical Industries Ltd Major Business
Table 105. Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Product and Services
Table 106. Teva Pharmaceutical Industries Ltd Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 108. Teva Pharmaceutical Industries Ltd Competitive Strengths & Weaknesses
Table 109. Amneal Pharmaceutical Inc Basic Information, Manufacturing Base and Competitors
Table 110. Amneal Pharmaceutical Inc Major Business
Table 111. Amneal Pharmaceutical Inc Leukotriene Inhibitors Product and Services
Table 112. Amneal Pharmaceutical Inc Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Amneal Pharmaceutical Inc Recent Developments/Updates
Table 114. Amneal Pharmaceutical Inc Competitive Strengths & Weaknesses
Table 115. Avet Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 116. Avet Pharmaceuticals Inc Major Business
Table 117. Avet Pharmaceuticals Inc Leukotriene Inhibitors Product and Services
Table 118. Avet Pharmaceuticals Inc Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Avet Pharmaceuticals Inc Recent Developments/Updates
Table 120. Avet Pharmaceuticals Inc Competitive Strengths & Weaknesses
Table 121. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 122. Aurobindo Pharma Major Business
Table 123. Aurobindo Pharma Leukotriene Inhibitors Product and Services
Table 124. Aurobindo Pharma Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Aurobindo Pharma Recent Developments/Updates
Table 126. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 127. GSK plc Basic Information, Manufacturing Base and Competitors
Table 128. GSK plc Major Business
Table 129. GSK plc Leukotriene Inhibitors Product and Services
Table 130. GSK plc Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. GSK plc Recent Developments/Updates
Table 132. GSK plc Competitive Strengths & Weaknesses
Table 133. Almirall, SA Basic Information, Manufacturing Base and Competitors
Table 134. Almirall, SA Major Business
Table 135. Almirall, SA Leukotriene Inhibitors Product and Services
Table 136. Almirall, SA Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Almirall, SA Recent Developments/Updates
Table 138. Almirall, SA Competitive Strengths & Weaknesses
Table 139. Merck & Co., Inc Basic Information, Manufacturing Base and Competitors
Table 140. Merck & Co., Inc Major Business
Table 141. Merck & Co., Inc Leukotriene Inhibitors Product and Services
Table 142. Merck & Co., Inc Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Merck & Co., Inc Recent Developments/Updates
Table 144. Merck & Co., Inc Competitive Strengths & Weaknesses
Table 145. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 146. Bausch Health Major Business
Table 147. Bausch Health Leukotriene Inhibitors Product and Services
Table 148. Bausch Health Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Bausch Health Recent Developments/Updates
Table 150. Bausch Health Competitive Strengths & Weaknesses
Table 151. Sandoz International GmbH Basic Information, Manufacturing Base and Competitors
Table 152. Sandoz International GmbH Major Business
Table 153. Sandoz International GmbH Leukotriene Inhibitors Product and Services
Table 154. Sandoz International GmbH Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Sandoz International GmbH Recent Developments/Updates
Table 156. Sandoz International GmbH Competitive Strengths & Weaknesses
Table 157. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 158. Pfizer Inc Major Business
Table 159. Pfizer Inc Leukotriene Inhibitors Product and Services
Table 160. Pfizer Inc Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. Pfizer Inc Recent Developments/Updates
Table 162. Pfizer Inc Competitive Strengths & Weaknesses
Table 163. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 164. AstraZeneca Major Business
Table 165. AstraZeneca Leukotriene Inhibitors Product and Services
Table 166. AstraZeneca Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. AstraZeneca Recent Developments/Updates
Table 168. AstraZeneca Competitive Strengths & Weaknesses
Table 169. Sanofi Basic Information, Manufacturing Base and Competitors
Table 170. Sanofi Major Business
Table 171. Sanofi Leukotriene Inhibitors Product and Services
Table 172. Sanofi Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 173. Sanofi Recent Developments/Updates
Table 174. Sanofi Competitive Strengths & Weaknesses
Table 175. Bayer AG Basic Information, Manufacturing Base and Competitors
Table 176. Bayer AG Major Business
Table 177. Bayer AG Leukotriene Inhibitors Product and Services
Table 178. Bayer AG Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 179. Bayer AG Recent Developments/Updates
Table 180. McKesson Corporation Basic Information, Manufacturing Base and Competitors
Table 181. McKesson Corporation Major Business
Table 182. McKesson Corporation Leukotriene Inhibitors Product and Services
Table 183. McKesson Corporation Leukotriene Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 184. Leukotriene Inhibitors Raw Material
Table 185. Key Manufacturers of Leukotriene Inhibitors Raw Materials
Table 186. Leukotriene Inhibitors Typical Distributors
Table 187. Leukotriene Inhibitors Typical Customers
LIST OF FIGURES
Figure 1. Leukotriene Inhibitors Picture
Figure 2. World Leukotriene Inhibitors Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Leukotriene Inhibitors Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Leukotriene Inhibitors Production (2017-2028) & (K Units)
Figure 5. World Leukotriene Inhibitors Average Price (2017-2028) & (US$/Unit)
Figure 6. World Leukotriene Inhibitors Production Value Market Share by Region (2017-2028)
Figure 7. World Leukotriene Inhibitors Production Market Share by Region (2017-2028)
Figure 8. North America Leukotriene Inhibitors Production (2017-2028) & (K Units)
Figure 9. Europe Leukotriene Inhibitors Production (2017-2028) & (K Units)
Figure 10. China Leukotriene Inhibitors Production (2017-2028) & (K Units)
Figure 11. Japan Leukotriene Inhibitors Production (2017-2028) & (K Units)
Figure 12. Leukotriene Inhibitors Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Leukotriene Inhibitors Demand (2017-2028) & (K Units)
Figure 15. World Leukotriene Inhibitors Consumption Market Share by Region (2017-2028)
Figure 16. United States Leukotriene Inhibitors Consumption (2017-2028) & (K Units)
Figure 17. China Leukotriene Inhibitors Consumption (2017-2028) & (K Units)
Figure 18. Europe Leukotriene Inhibitors Consumption (2017-2028) & (K Units)
Figure 19. Japan Leukotriene Inhibitors Consumption (2017-2028) & (K Units)
Figure 20. South Korea Leukotriene Inhibitors Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Leukotriene Inhibitors Consumption (2017-2028) & (K Units)
Figure 22. India Leukotriene Inhibitors Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Leukotriene Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Leukotriene Inhibitors Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Leukotriene Inhibitors Markets in 2021
Figure 26. United States VS China: Leukotriene Inhibitors Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Leukotriene Inhibitors Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Leukotriene Inhibitors Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Leukotriene Inhibitors in United States
Figure 30. Key Producers and Market Share of Leukotriene Inhibitors in China
Figure 31. Key Producers and Market Share of Leukotriene Inhibitors in Rest of World
Figure 32. World Leukotriene Inhibitors Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Leukotriene Inhibitors Production Value Market Share by Type in 2021
Figure 34. Montelukast
Figure 35. Zafirlukast
Figure 36. Proust
Figure 37. Other
Figure 38. World Leukotriene Inhibitors Production Market Share by Type (2017-2028)
Figure 39. World Leukotriene Inhibitors Production Value Market Share by Type (2017-2028)
Figure 40. World Leukotriene Inhibitors Average Price by Type (2017-2028) & (US$/Unit)
Figure 41. World Leukotriene Inhibitors Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 42. World Leukotriene Inhibitors Production Value Market Share by Application in 2021
Figure 43. Asthma
Figure 44. COPD
Figure 45. Allergic Rhinitis
Figure 46. Other
Figure 47. World Leukotriene Inhibitors Production Market Share by Application (2017-2028)
Figure 48. World Leukotriene Inhibitors Production Value Market Share by Application (2017-2028)
Figure 49. World Leukotriene Inhibitors Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of Leukotriene Inhibitors in 2021
Figure 51. Manufacturing Process Analysis of Leukotriene Inhibitors
Figure 52. Leukotriene Inhibitors Industrial Chain
Figure 53. Distribution Channel Breakdown for Leukotriene Inhibitors Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. Leukotriene Inhibitors Picture
Figure 2. World Leukotriene Inhibitors Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Leukotriene Inhibitors Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Leukotriene Inhibitors Production (2017-2028) & (K Units)
Figure 5. World Leukotriene Inhibitors Average Price (2017-2028) & (US$/Unit)
Figure 6. World Leukotriene Inhibitors Production Value Market Share by Region (2017-2028)
Figure 7. World Leukotriene Inhibitors Production Market Share by Region (2017-2028)
Figure 8. North America Leukotriene Inhibitors Production (2017-2028) & (K Units)
Figure 9. Europe Leukotriene Inhibitors Production (2017-2028) & (K Units)
Figure 10. China Leukotriene Inhibitors Production (2017-2028) & (K Units)
Figure 11. Japan Leukotriene Inhibitors Production (2017-2028) & (K Units)
Figure 12. Leukotriene Inhibitors Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Leukotriene Inhibitors Demand (2017-2028) & (K Units)
Figure 15. World Leukotriene Inhibitors Consumption Market Share by Region (2017-2028)
Figure 16. United States Leukotriene Inhibitors Consumption (2017-2028) & (K Units)
Figure 17. China Leukotriene Inhibitors Consumption (2017-2028) & (K Units)
Figure 18. Europe Leukotriene Inhibitors Consumption (2017-2028) & (K Units)
Figure 19. Japan Leukotriene Inhibitors Consumption (2017-2028) & (K Units)
Figure 20. South Korea Leukotriene Inhibitors Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Leukotriene Inhibitors Consumption (2017-2028) & (K Units)
Figure 22. India Leukotriene Inhibitors Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Leukotriene Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Leukotriene Inhibitors Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Leukotriene Inhibitors Markets in 2021
Figure 26. United States VS China: Leukotriene Inhibitors Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Leukotriene Inhibitors Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Leukotriene Inhibitors Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Leukotriene Inhibitors in United States
Figure 30. Key Producers and Market Share of Leukotriene Inhibitors in China
Figure 31. Key Producers and Market Share of Leukotriene Inhibitors in Rest of World
Figure 32. World Leukotriene Inhibitors Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Leukotriene Inhibitors Production Value Market Share by Type in 2021
Figure 34. Montelukast
Figure 35. Zafirlukast
Figure 36. Proust
Figure 37. Other
Figure 38. World Leukotriene Inhibitors Production Market Share by Type (2017-2028)
Figure 39. World Leukotriene Inhibitors Production Value Market Share by Type (2017-2028)
Figure 40. World Leukotriene Inhibitors Average Price by Type (2017-2028) & (US$/Unit)
Figure 41. World Leukotriene Inhibitors Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 42. World Leukotriene Inhibitors Production Value Market Share by Application in 2021
Figure 43. Asthma
Figure 44. COPD
Figure 45. Allergic Rhinitis
Figure 46. Other
Figure 47. World Leukotriene Inhibitors Production Market Share by Application (2017-2028)
Figure 48. World Leukotriene Inhibitors Production Value Market Share by Application (2017-2028)
Figure 49. World Leukotriene Inhibitors Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of Leukotriene Inhibitors in 2021
Figure 51. Manufacturing Process Analysis of Leukotriene Inhibitors
Figure 52. Leukotriene Inhibitors Industrial Chain
Figure 53. Distribution Channel Breakdown for Leukotriene Inhibitors Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
